Plain-English translation of NCT07732907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Researchers are studying the risk of a rare brain infection called progressive multifocal leukoencephalopathy (PML) in people with multiple sclerosis who have taken . This study will look at cases where PML occurred after taking the medication, to understand how common this risk is and what factors might make someone more likely to develop this infection.
Although this medication is used to treat multiple sclerosis, there is a potential risk of developing a rare but serious brain infection. By reviewing cases where this has happened, researchers want to better understand this risk, identify which patients might be most vulnerable, and help doctors make safer treatment decisions.
You likely qualify if…
You likely don't qualify if…
This is not a treatment study — researchers will review your existing medical records and reported case information that has already been submitted. You will not receive any new medication or undergo new procedures. The researchers will use your information to better understand the connection between this medication and the rare brain infection.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States